An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked Hyper-IgM syndrome)

被引:0
|
作者
Webster, EA
Khakoo, AY
Mackus, WJM
Karpusas, M
Thomas, DW
Davidson, A
Christian, CL
Lederman, S
机构
[1] Columbia Univ, Lab Mol Immunol, New York, NY 10032 USA
[2] Biogen Corp, Cambridge, MA USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
[4] Univ Florida, Jacksonville, FL USA
来源
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 06期
关键词
D O I
10.1002/1529-0131(199906)42:6<1291::AID-ANR29>3.0.CO;2-#
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyper-IgM syndrome (HIM) is a rare immunodeficiency disorder that has been associated with the development of symptoms and clinical features characteristic of rheumatoid arthritis (RA), We describe a patient with HIM and severe erosive arthritis with prominent nodules in the absence of detectable serum rheumatoid factor, Because HIM results from defects in either T cell CD154 (CD40 ligand) expression or abnormal CD40 signaling, the molecular basis of the patient's disease was analyzed. Activated CD4+ T cells failed to express surface CD154 protein, and molecular analysis of CD154 complementary DNA re revealed a nucleotide transversion resulting in the nonconservative amino acid substitution G-D at amino acid 257, This case indicates that defective CD154-dependent CD40 signaling can be associated with susceptibility to a severe inflammatory arthritis that has both similarities to and differences from idiopathic RA.
引用
收藏
页码:1291 / 1296
页数:6
相关论文
共 50 条
  • [21] Visceral Leishmaniasis May Unmask X-linked Hyper-IgM Syndrome
    Luis Ignacio Gonzalez-Granado
    Nerea Dominguez-Pinilla
    Fernando Gallego-Bustos
    Jesús Ruiz-Contreras
    Luis M. Allende
    Journal of Clinical Immunology, 2016, 36 : 363 - 365
  • [22] Targeted gene therapy in the treatment of X-linked hyper-IgM syndrome
    Kuo, C. Y.
    Long, J. D.
    Campo, B.
    Hoban, M. D.
    Joglekar, A. V.
    Romero, Z.
    Hollis, R. P.
    Kohn, D. B.
    HUMAN GENE THERAPY, 2016, 27 (11) : A41 - A41
  • [23] Visceral Leishmaniasis May Unmask X-linked Hyper-IgM Syndrome
    Ignacio Gonzalez-Granado, Luis
    Dominguez-Pinilla, Nerea
    Gallego-Bustos, Fernando
    Ruiz-Contreras, Jesus
    Allende, Luis M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (04) : 363 - 365
  • [24] Targeted Gene Therapy in the Treatment of X-Linked Hyper-IgM Syndrome
    Kuo, Caroline Y.
    Hoban, Megan D.
    Joglekar, Alok V.
    Kohn, Donald B.
    MOLECULAR THERAPY, 2014, 22 : S36 - S36
  • [25] Targeted Gene Therapy in the Treatment of X-Linked Hyper-Igm Syndrome
    Kuo, Caroline Y.
    Joglekar, Alok V.
    Kohn, Donald B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 362 - 362
  • [26] Targeted Gene Insertion for the Treatment of X-Linked Hyper-IgM Syndrome
    Kuo, Caroline Y.
    Long, Joseph D.
    Campo-Fernandez, Beatriz
    de Oliveira, Satiro
    Cooper, Aaron R.
    Romero, Zulema
    Hoban, Megan D.
    Joglekar, Alok V.
    Lill, Georgia R.
    Kaufman, Michael L.
    Fitz-Gibbon, Sorel
    Wang, Xiaoyan
    Hollis, Roger P.
    Kohn, Donald B.
    MOLECULAR THERAPY, 2018, 26 (05) : 373 - 373
  • [27] X-linked hyper-IGM syndrome and mutations of the CD40 ligand gene.
    Seyama, K
    Bajorath, J
    Nonoyama, S
    Ganggsass, J
    Aruffo, A
    Ochs, HD
    FASEB JOURNAL, 1996, 10 (06): : 1206 - 1206
  • [28] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME
    ALLEN, RC
    ARMITAGE, RJ
    CONLEY, ME
    ROSENBLATT, H
    JENKINS, NA
    COPELAND, NG
    BEDELL, MA
    EDELHOFF, S
    DISTECHE, CM
    SIMONEAUX, DK
    FANSLOW, WC
    BELMONT, J
    SPRIGGS, MK
    SCIENCE, 1993, 259 (5097) : 990 - 993
  • [29] Immune reconstitution in x-linked hyper-IgM syndrome with recombinant CD40 ligand
    Jain, Ashish
    Nelson, David
    Kovacs, Jospeh
    Liu, Shuying
    Fleisher, Thomas
    Fanslow, William
    Ochs, Hans
    Strober, Warren
    CLINICAL IMMUNOLOGY, 2007, 123 : S129 - S129
  • [30] Mechanotransduction governs CD40 function and underlies X-linked hyper-IgM syndrome
    Choi, Hyun-Kyu
    Travaglino, Stefano
    Muenchhalfen, Matthias
    Goerg, Richard
    Zhong, Zhe
    Lyu, Jintian
    Reyes-Aguilar, David M.
    Wienands, Juergen
    Singh, Ankur
    Zhu, Cheng
    SCIENCE ADVANCES, 2024, 10 (46):